Podcast appearances and mentions of Kyle Rudolph

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

Fantasy football is a tradition for millions — but is it still fun when it costs $1,500 for a three-night draft trip in the Bahamas?In this episode, three speakers break down ESPN's Ultimate Fantasy Football Draft Weekend, hosted in the Bahamas. They question whether the high-end package lives up to the hype or if it's just a flashy way to squeeze more money from a fading fantasy football audience.

Fantasy football is a tradition for millions — but is it still fun when it costs $1,500 for a three-night draft trip in the Bahamas?In this episode, three speakers break down ESPN's Ultimate Fantasy Football Draft Weekend, hosted in the Bahamas. They question whether the high-end package lives up to the hype or if it's just a flashy way to squeeze more money from a fading fantasy football audience.

Top Minnesota Vikings of the 21st Century: Peterson, Moss, Jefferson, or Culpepper?—In this episode of 'The Real Forno Show,' host Tyler Forness and producer Dave Stefano dive into a lively debate over the Minnesota Vikings' Quarter Century Team. They react to ESPN's controversial exclusion of Adrian Peterson from the NFL Quarter Century team, and discuss which Vikings players would make up their best team of the last 25 years. Positions analyzed include quarterback, running back, wide receiver, tight end, offensive and defensive line, linebacker, cornerback, and special teams. From the dominant peaks of Randy Moss and Justin Jefferson to the solid performance of players like Kyle Rudolph and Brian McKinney, the duo leaves no stone unturned in crafting their ultimate Vikings lineup. 00:00 Introduction and Host Welcome 01:23 Quarter Century Team Overview 06:43 Quarterback Selection Discussion 14:01 Running Back and Fullback Choices 18:55 Wide Receiver Picks and Analysis 25:37 Tight End and Offensive Line Selections 28:39 Offensive Line Woes and Hopes 29:36 Defensive Line Legends 35:13 Linebacker Lineup 38:53 Cornerback Choices 43:36 Safety Selections 48:11 Special Teams Standouts 53:46 Show Wrap-Up and Announcements FAN WITH US!!! Tyler Forness @TheRealForno of Vikings 1st & SKOL @Vikings1stSKOL and A to Z Sports @AtoZSportsNFL and Dave Stefano @Luft_Krigare producing this Vikings 1st & SKOL production, on the @RealFornoShow. Podcasts partnered with Fans First Sports Network @FansFirstSN and Fans First Sports Network's NFL feed @FFSN_NFL. ____________________________________________________________ ⭐️ Subscribe to us here! - https://www.youtube.com/@vikings1stskol92 ⭐️ Our Twitter can be found at @Vikings1stSKOL ⭐️ Tyler Forness can be read at A to Z Sports - https://atozsports.com/nfl/minnesota-vikings-news/ ⭐️ At Fans First Sports Network - https://www.ffsn.app/teams/minnesota-vikings/ ⭐️ On Facebook - https://www.facebook.com/vikings1standskol ⭐️ Watch the live show here: https://youtu.be/o55WnJ_fUj0 Learn more about your ad choices. Visit megaphone.fm/adchoices

Another busy day on radio row in New Orleans as Stugotz and Billy sit down with Ed Reed, Kristian Fulton, Vernon Davis, Logan Ryan, Joey Porter, Puka Nacua, Reggie Bush, Cameron Dickerer, Kyle Rudolph, Joe Montana, and Trey Hendrickson. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Another busy day on radio row in New Orleans as Stugotz and Billy sit down with Ed Reed, Kristian Fulton, Vernon Davis, Logan Ryan, Joey Porter, Puka Nacua, Reggie Bush, Cameron Dickerer, Kyle Rudolph, Joe Montana, and Trey Hendrickson. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Another busy day on radio row in New Orleans as Stugotz and Billy sit down with Ed Reed, Kristian Fulton, Vernon Davis, Logan Ryan, Joey Porter, Puka Nacua, Reggie Bush, Cameron Dickerer, Kyle Rudolph, Joe Montana, and Trey Hendrickson. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Thanks to XFinity for bringing us to New Orleans!When we're streaming shows live, Xfinity Internet has a 99.9% network reliability, ultra low lag, and reduced buffering so we never miss a moment of our favorite entertainment. You can enjoy that same 99.9 percent reliability whether you're streaming Sunday's game or gaming with your friends to get you through the offseason. Game, stream, chat or do it all at once with XFinity. You can also count on fast speeds and reliability, whether you're streaming your favorite show in the house or out at a sports game. With WiFi PowerBoost — only from Xfinity Mobile — you can get fast speeds up to a gig at home or on the go. Enjoy unmatched value while staying connected to the ones you love with the most reliable network and nationwide 5G. Visit XFinity.com to learn more. Welcome to a VERY special edition of Andy & Ari On3 - presented by Xfinity. From New Orleans, Andy & Ari have a very special guest joining them in former Notre Dame and NFL tight end Kyle Rudolph. Also, Andy & Ari go through their conspiracy theories and dynasties in the sport of football as a whole. Stick around for the end to watch Andy teach Ari how to eat chicken wings for the big game this weekend. (0:00-4:23) Introduction from New Orleans(4:24-7:44) Philadelphia vs Kansas City in Super Bowl(7:45-14:03) Dynasties in the sport  (14:04-15:14) Xfinity Ad(15:15-30:16) The Quarterback Position(30:17-51:36) Kyle Rudolph joins the show(51:37-59:49) Andy Teaches Ari How to eat wings(59:50-1:00:37) Conclusion, Big thanks to Xfinity Watch us live on YouTube! https://youtube.com/live/BtCXA9aCC-s Hosts: Andy Staples, Ari WassermanProducer: River Bailey

CEO of Vaynermedia Gary Vanynerchuck joins the show to talk about his passions in business, and the state of the Jets. 2x Super Bowl Champion Eli Manning then joins to talk about his Hall of Fame candidacy. Also, 2x Pro Bowl TE Kyle Rudolph stops by the Airstream Studio. Plus, Evan is worried about bad breath. Learn more about your ad choices. Visit podcastchoices.com/adchoices

LIVE from Radio Row at Super Bowl LIX in New Orleans, the DNVR Broncos Podcast is on sight with all of the latest news surrounding the Denver Broncos, Bo Nix, Sean Payton and Pat Surtain II including many interviews.Champ Bailey joins the show to give his take on Pat Surtain and what it would mean for him to win defensive player of the year.Steve Atwater also joins to dicuss all things Broncos. He has gotten to be up close and personal with Bo Nix. Is Bo really the guy? What are his thoughts on Pat Surtain being the favorite to win DPOY.Kyle Rudolph stops by to give his take on what Sean Payton and the Denver Broncos need to improve. Is tight end the biggest need for the Broncos and can Tyler Warren be that guy?Prince Amukamara and Dan Orlovsky also stop by and tell us who they want to win the Super Bowl between the Eagles and Chiefs.How far away are the Denver Broncos from being in the Super Bowl like the Kansas City Chiefs and Philadelphia Eagles are? What does Bo Nix need to do to compete with Patrick Mahomes? On the DNVR Broncos Podcast, Super Bowl 50 Champion Todd Davis, Zac Stevens and Henry Chisholm are coming to you LIVE from Radio Row at Super Bowl LIX in New Orleans to break down the latest in Broncos Country and with the Super Bowl. Intro: 0:00Champ Bailey on Pat Surtain: 19:07Prince Amukamara joins the show: 23:50Dan Orlovsky joins the show: 30:05Kyle Rudolph joins the show: 37:37 An ALLCITY Network Production PARTY WITH US: https://thednvr.com/events ALL THINGS DNVR: https://linktr.ee/dnvrsports MERCH: https://store.allcitynetwork.com/collections/dnvr-locker SUBSCRIBE: https://www.youtube.com/c/DNVR_Sports Breck Brew Ice Deck Giveaway: http://breckbrew.com/icedeckbet365: Go to https://www.bet365.com/hub/en-us/app-hero-banner-1?utm_source=affiliate&utm_campaign=usapp&utm_medium=affiliate&affiliate=365_03485318 or use code DNVR365 when you sign up. Must be 21+ and physically located in CO.  Please gamble responsibly. If you or someone you know has a gambling problem and wants help call or TEXT 1-800-GAMBLER Empire Today: Schedule a free in-home estimate today! All listeners can receive a $350 OFF discount when they use the promo code DNVR. Restrictions apply. See https://empiretoday.com/dnvr for details  EveryPlate: With affordable dinners for just $5.99 per serving, PLUS 50% off your first box, EveryPlate helps you save money for a stress-free holiday! Get this amazing deal by going to https://EveryPlate.com/PODCAST and entering code dnvr599. Get Coors Light delivered straight to your door with Instacart by going to https://coorslight.com/DNVR. Celebrate Responsibly. Coors Brewing Company, Golden, Colorado.  Download the Circle K app and join the Inner Circle or visit https://www.circlek.com/inner-circle! Download the Gametime app, create an account, and use code DNVR for $20 off your first purchase. Terms apply. Exclusively for our listeners, Shady Rays is giving out their best deal of the season. Head to https://shadyrays.com and use codeoadoutdoors.pxf.io/allcity: DNVR for 35% off polarized sunglasses. Try for yourself the shades rated 5 stars by over 300,000 people. Birdcall: Right now, DNVR fans can score 20% off at Birdcall with promo code “DNVR”! Get down to Birdcall or order online at https://eatbirdcall.com and grab this offer now through the end of the month. Offer valid for any order of $10 or more. Limit 1 per guest per day. Not valid on catering orders or through 3rd party delivery sites. Use code DNVRBRONCOS50 to get 50% OFF your first Factor box and 20% off your next month with any active subscription at https://factormeals.com/dnvrbroncos50. Check out FOCO merch and collectibles here https://foco.vegb.net/DNVRBroncos and use promo code “DNVR10” for 10% off your order on all non Pre Order items. Rugged Road: Gear up for your next adventure with Rugged Road Coolers - Your ultimate outdoor companion! Head to http://ruggedroadoutdoors.pxf.io/ALLCITY and use code DNVR for 10% off!   Hello Fresh - Get 10 FREE meals at https://hellofresh.com/freebroncos. Applied across 7 boxes, new subscribers only, varies by plan. When you shop through links in the description, we may earn affiliate commissions. Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.

CEO of Vaynermedia Gary Vanynerchuck joins the show to talk about his passions in business, and the state of the Jets. 2x Super Bowl Champion Eli Manning then joins to talk about his Hall of Fame candidacy. Also, 2x Pro Bowl TE Kyle Rudolph stops by the Airstream Studio. Plus, Evan is worried about bad breath. Learn more about your ad choices. Visit podcastchoices.com/adchoices

CEO of Vaynermedia Gary Vanynerchuck joins the show to talk about his passions in business, and the state of the Jets. 2x Super Bowl Champion Eli Manning then joins to talk about his Hall of Fame candidacy. Also, 2x Pro Bowl TE Kyle Rudolph stops by the Airstream Studio. Plus, Evan is worried about bad breath. Learn more about your ad choices. Visit podcastchoices.com/adchoices

CEO of Vaynermedia Gary Vanynerchuck joins the show to talk about his passions in business, and the state of the Jets. 2x Super Bowl Champion Eli Manning then joins to talk about his Hall of Fame candidacy. Also, 2x Pro Bowl TE Kyle Rudolph stops by the Airstream Studio. Plus, Evan is worried about bad breath. Learn more about your ad choices. Visit podcastchoices.com/adchoices

CEO of Vaynermedia Gary Vanynerchuck joins the show to talk about his passions in business, and the state of the Jets. 2x Super Bowl Champion Eli Manning then joins to talk about his Hall of Fame candidacy. Also, 2x Pro Bowl TE Kyle Rudolph stops by the Airstream Studio. Plus, Evan is worried about bad breath. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Kyle Rudolph

KYLE RUDOLPH JOINS by Two Men On

AWadd takes us into the show as always with The Sports App live from New Orleans as we break down all of the biggest storylines and moments from the NFL, NBA, NHL, and College Basketball. Craig Carton joins the show with us as we talk about sports gambling and break down the state of the NBA as AWadd wants a reason to tune in. Kyle Rudoplh joins AWadd on the show next to talk all things football and we go all across the sports world. Matt and Drab of The Sports Junkies join AWadd on the show next to talk about the trip to New Orleans so far and we break down some fun prop bets.

Former Vikings and Giants tight end Kyle Rudolph talks to Inside The Birds and 97.3 ESPN live from Radio Row in New Orleans to preview Super Bowl LIX between the Eagles and Chiefs. #eagles #philadelphiaeagles #chiefs #kansascitychiefs #flyeaglesfly #chiefskingdom #superbowllix #jalenhurts #jalencarter #saquonbarkley #patrickmahomes #traviskelce #andyreid

2.5.25 Hour 3 1:00- Wizards- Greg Finberg, NFL- Benjamin Brown 15:00- Former All-Pro WR Ed McCaffrey joins G&D to discuss his family tree of NFL talent, and Luke's first year with the Commanders. 32:00- Former Pro-Bowl TE Kyle Rudolph joins G&D to discuss Zach Ertz and his huge season in Washington.

On today's interview episode we are joined by former NFL & Notre Dame Tight End Kyle Rudolph. We get into the in-state rivalry between Notre Dame and Indiana, his prediction for the College Football Playoff and who he believes is the best choice for the Bears next head coach.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/redlineradio

Hutt and Chad discuss Eric Bieniemy, the once highly sought-after NFL head coaching prospect, out at UCLA as OC. Plus, OutKick Senior College Writer, Trey Wallace live from the Atlanta, Georgia to preview the SEC Championship game. Former Notre Dame TE Kyle Rudolph joins the show to discuss his support of veterans and their families in the Twin Cities and his time playing Tight End at Notre Dame. OutKick Host “The Fade”, Kelly In Vegas with her best bets of the weekend. Learn more about your ad choices. Visit megaphone.fm/adchoices

Lance Briggs and Alex Brown are back for another episode of the Briggs and Brown Show! On today's episode Lance and Alex talk about what they would do if they won the Powerball and what's the craziest request they ever got for money! Plus, Lance Briggs responds to the story from Kyle Rudolph about the hardest hit Kyle ever received along with whether or not Lance or Alex would ever support the guardian caps seen used throughout the league this year. The guys also dive into the Bears vs Commanders Preview! All that and more on the Briggs and Brown Show!

Bo Nix Thursday Night and the Saints are officially on Quit watch (00:00:00-00:07:58). We talk playoff baseball and an incredible Guardians win and the Mets are dead because the Dodgers have too many dudes (00:07:58-00:14:09). NFL Week 7 picks and preview including the Packers gross jerseys, Hank's trap game, Lions/Vikings and a Super Bowl Rematch (00:14:09-01:29:55). Fantasy Fuccbois and our contest picks (01:29:55-01:36:40). Kyle Rudolph joins the show in studio to talk football, catching Tom Brady's last touchdown pass, the hardest he was ever hit, the Minnesota Love Boat and more (01:36:40-02:29:43). Francis Ngannou joins the show ahead of his return to MMA via a hologram and we talk fighting, Jackass and more (02:29:43-02:56:41). We finish with Fyre Fest of the week (02:56:41-03:13:38).You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/pardon-my-take

Cole Kmet and Kyle Rudolph stop byYou can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/barstoolyak

Kay Adams hosted the latest episode of 'Up & Adams' on FanDuel TV and YouTube live! In today's episode, Kay previews the Buffalo Bills versus Miami Dolphins on Thursday night and the Cincinnati Bengals facing the Kansas City Chiefs on Sunday. Next, former NFL quarterback Ryan Fitzpatrick gives his thoughts on the Bills-Dolphins matchup, if the Los Angeles Rams can weather the storm of early season injuries, and Arizona Cardinals quarterback Kyler Murray's comments. Then, Kay reveals her top fantasy football sleepers for Week 2 in the NFL. After that, former Pro Bowl tight end Kyle Rudolph discusses the issues with New York Giants quarterback Daniel Jones, the impressive play of Minnesota Vikings quarterback Sam Darnold, and if he saw a healthy Atlanta Falcons quarterback Kirk Cousins in Week 1. Finally, Matt Hamilton highlights Indianapolis Colts quarterback Anthony Richardson's Week 1 performance.

The middle stretch features a catch-up with Kyle Rudolph, then Lavelle on the Hotline, before Gopher football coach PJ Fleck recaps Saturday's blowout over Rhode Island!

The middle stretch features a catch-up with Kyle Rudolph, then Lavelle on the Hotline, before Gopher football coach PJ Fleck recaps Saturday's blowout over Rhode Island!

Former Vikings tight end talks 2024 season.

For todays episode, I had both NHL & NFL stars that came together to say hello from Edgewood Lake Tahoe! Pro Bowl NFL wide receivers, Kyle Rudolf & Adam Thielen, as well as the NHL's, TJ Oshie & Zach Bogosian were participating in the 35th annual American Century Celebrity Championship!They spoke on their experiences participating in the tournament as well as their love of golf. Each guest also shared who their first concert was!Make sure to visit www.SaltOptics.com to pick up a hand made pair of premium eyewear crafted in Japan. They have many different styles that are light weight, durable & look amazing! @saltopticsAlso take a look at www.UNRL.com to pick up some of the shirts I am wearing in my interviews at the American Century Championship! UNRL has clothing that looks & feels great for golf, exercise & many other settings. @UNRLcoFor more exclusive content, follow the Jim on Base Show on social media (Twitter/Instagram/TikTok): @JimonBaseShow

Click here to subscribe, rate, and review the newest episodes of GoJo and Golic!  If you or someone you know has a gambling problem, crisis counseling, and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) (IL/IN/MI/NJ/PA/WV/WY), 1-800-NEXT STEP (AZ), 1-800-522-4700 (CO/NH), 888-789-7777/visit http://ccpg.org/chat (CT), 1-800-BETS OFF (IA), 1-877-770-STOP (7867) (LA), 877-8-HOPENY/text HOPENY (467369) (NY), visit OPGR.org (OR), call/text TN REDLINE 1-800-889-9789 (TN), or 1-888-532-3500 (VA). 21+ (18+ WY). Physically present in AZ/CO/CT/IL/IN/IA/LA/MI/NJ/ NY/PA/TN/VA/WV/WY only. New customers only. Min. $5 deposit required. Eligibility restrictions apply. See http://draftkings.com/sportsbook for details. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Common Man Progrum HOUR 1 --Car Honk -- Tragic Vikings Story – Kyle Rudolph

Common Man Progrum HOUR 1 --Car Honk -- Tragic Vikings Story – Kyle Rudolph

Common Man Progrum HOUR 1 --Car Honk -- Tragic Vikings Story – Kyle Rudolph

--PA is joined by former Vikings Kyle Rudolph and Ben Goessling!

Click here to subscribe, rate, and review the newest episodes of GoJo and Golic!  If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) (IL/IN/MI/NJ/PA/WV/WY), 1-800-NEXT STEP (AZ), 1-800-522-4700 (CO/NH), 888-789-7777/visit http://ccpg.org/chat (CT), 1-800-BETS OFF (IA), 1-877-770-STOP (7867) (LA), 877-8-HOPENY/text HOPENY (467369) (NY), visit OPGR.org (OR), call/text TN REDLINE 1-800-889-9789 (TN), or 1-888-532-3500 (VA). 21+ (18+ WY). Physically present in AZ/CO/CT/IL/IN/IA/LA/MI/NJ/ NY/PA/TN/VA/WV/WY only. New customers only. Min. $5 deposit required. Eligibility restrictions apply. See http://draftkings.com/sportsbook for details. Learn more about your ad choices. Visit megaphone.fm/adchoices

Wolves lose both at home, so emptying the notebook and lamenting a 2-2 series vibe. Former Vikings TE Kyle Rudolph joins with his perspective on the howl, with a bunch of talkbacks and takes to fill the opening hour!

In Hour 2… [02:10] Kyle Rudolph Talks TWolves & NFL Offseason GoJo and Golic chat with Kyle Rudolph about him and his wife Jordan being photographed with Travis Kelce and Taylor Swift, the New York Giants bringing in Drew Lock to compete with Daniel Jones, and the Minnesota Vikings drafting QB J.J. McCarthy. Rudolph, a long-time Minnesota resident, talks about the Timberwolves' evolution as they've built around Karl-Anthony Towns, Anthony Edwards' emergence, and their playoff prospects. [23:40] NY Giants & NE Patriots QB Competitions The guys discuss Jeremiah's claim that Drew Lock could challenge Daniel Jones for the Giants' starting QB spot and Jacoby Brissett's comments on competing with rookie Drake Maye for the Patriots' QB job. [34:15] Bucks vs. Pacers & Knicks vs. 76ers Game Previews Claudia, GoJo, and Golic break down pivotal NBA playoff games between the Bucks and Pacers and the Knicks and 76ers, examining the impact of Giannis and Dame's injuries for the Bucks and the series' potential outcomes. [00:00] This, That, and the Third Sorry, Tiger Woods. We don't like Sun Day Red's holding back on the red merch. The heroic actions of "Bee Guy" at Chase Field and the release of his epic Topps baseball card commemorating his efforts. Then, Emerson's new biker stache. Click here to subscribe, rate, and review the newest episodes of GoJo and Golic!  If you or someone you know has a gambling problem, crisis counseling and referral services can be accessed by calling 1-800-GAMBLER (1-800-426-2537) (IL/IN/MI/NJ/PA/WV/WY), 1-800-NEXT STEP (AZ), 1-800-522-4700 (CO/NH), 888-789-7777/visit http://ccpg.org/chat (CT), 1-800-BETS OFF (IA), 1-877-770-STOP (7867) (LA), 877-8-HOPENY/text HOPENY (467369) (NY), visit OPGR.org (OR), call/text TN REDLINE 1-800-889-9789 (TN), or 1-888-532-3500 (VA). 21+ (18+ WY). Physically present in AZ/CO/CT/IL/IN/IA/LA/MI/NJ/ NY/PA/TN/VA/WV/WY only. New customers only. Min. $5 deposit required. Eligibility restrictions apply. See http://draftkings.com/sportsbook for details. Learn more about your ad choices. Visit megaphone.fm/adchoices

Lance talks with The Baseball5 guys: Kyle Rudolph and Ben Kelly. Tune in!

Kay Adams hosted the latest episode of 'Up & Adams' on FanDuel TV and YouTube! On today's episode, Kay and Matt Hamilton react to the NFL banning the hip-drop tackle, the Washington Commanders' draft plans, and if the Arizona Cardinals will take a step next season. Next, former Pro Bowl tight end Kyle Rudolph discusses the type of style he looks to bring to the broadcast booth, his thoughts on the hip-drop tackle ban, the Minnesota Vikings' quarterback options after moving on from Kirk Cousins, and wide receiver Justin Jefferson's ongoing contract situation. Then, former Kentucky Wildcats linebacker Trevin Wallace talks about his combine performance, how he's handled the off the field part of the draft process, and his thoughts on a few teams that could use his services. Finally, Kay highlights one thing to know about former North Carolina State defensive tackle Darius Robinson ahead of the draft.

Mark Willard and Kyle Rudolph look ahead to the Super Bowl with a full break down on what the Chiefs and 49ers will have to do to win this year's title. The guys explain why fans are not actually tired of the Chiefs' success despite what everyone may say. Kyle provides perspective on the innate irony of holding the Big Game in Las Vegas. Plus, the guys shut down the head coaching carousel and open up the offseason quarterback carousel and discuss the many teams that may or may not look to make a major change under center.See omnystudio.com/listener for privacy information.

Aaron Torres and Kyle Rudolph react live to the NFC Championship Game, as the 49ers overcome a first half deficit to beat the Lions and advance to the Super Bowl. The guys dive into Dan Campbell's controversial decisions to attempt to convert a pair of crucial 4th downs. Aaron and Kyle react to the Chiefs' win over the Ravens and break down what makes Kansas City such a special franchise. Plus, FSR and 95.7 The Game Host Mark Willard joins the guys to give his thoughts on his 49ers heading to the Super Bowl!See omnystudio.com/listener for privacy information.

Mark Willard and Kyle Rudolph take to the air moments after the Packers complete their 48-point dominating performance over the second-seeded Dallas Cowboys. The guys look at what this means for the future of Mike McCarthy, Dak Prescott, and all aspects of the Cowboys franchise. Mark and Kyle dive into the Chiefs win over the Dolphins and examine how much blame Tua Tagovailoa should be receiving. The guys talk the impressive victory for CJ Stroud and the Texans. Plus, the guys react live to the first half of the Lions and Rams!See omnystudio.com/listener for privacy information.

Mark Willard and Kyle Rudolph analyze the wild ending from Saturday's showdown between the Lions and Cowboys. Kyle calls for the officiating crew to face some sort of discipline after their consistent terrible calls from throughout the season. Mark and Kyle react to Lamar Jackson's 5 TD day, and breakdown why he pulled away in the MVP race after his performance the last 2 weeks. The guys react live to the Packers beat down of the banged up Vikings, and explain why the Cowboys and Dolphins are perfect examples of paper tigers.See omnystudio.com/listener for privacy information.

Mark Willard and Kyle Rudolph debate the MVP race between Brock Purdy and Dak Prescott, and discuss who hold the lead after today's results. Mark believes the race is all but over, because Brock Purdy or Christian McCaffery deserves the award. The guys discuss why the Bills might be the least-desirable team a team would want to face in the playoffs, and argue why it's important for coaches to learn situational football and not bank on analytics. Plus, the guys react to the Ravens and Jaguars Sunday Night clash, and discuss why it's time for Trevor Lawrence to put up, or shut up.See omnystudio.com/listener for privacy information.

Former NFL tight end joined the show.

Part One of the Good Morning Football Podcast begins with the Cowboys hosting the Eagles on Sunday Night Football.  Hosts Colleen Wolfe, Kyle Brandt, Peter Schrager and Super Bowl Champion Jason McCourty discuss what a win would mean for Dallas. Peter delivers some backup QB trivia before the table examines how the Bills can keep their playoff hopes alive. Plus, a surprise MVP prediction from Kyle. Stay tuned for Ryan Fitzpatrick and Kyle Rudolph coming up in Part Two of the GMFB Podcast! The Good Morning Football Podcast is part of the NFL Podcast NetworkSee omnystudio.com/listener for privacy information.

Part Two of the Good Morning Football Podcast begins with Ryan Fitzpatrick dropping by.  Hosts Colleen Wolfe, Kyle Brandt, Peter Schrager and Super Bowl Champion Jason McCourty discuss tonight's Patriots/Steelers matchup along with Ryan's thoughts on the QB situation in NY.  With Rams/Ravens this week, which WR duo has a bigger game?  Does Justin Fields or Zach Wilson have more at stake this weekend?  Kyle Rudolph discusses the future of Kirk Cousins with the Vikings.  Plus, Adam Rank takes us into the Fantasy Postseason with this Week 14 thoughts! The Good Morning Football Podcast is part of the NFL Podcast NetworkSee omnystudio.com/listener for privacy information.

Former Vikings tight end Kyle Rudolph joins the show to talk about his recently announced retirement as well as playing with Tom Brady

Dan is on vacation in Africa. Riggs, Frankie and Trent start the show discussing Tiger Woods joining the PGA TOUR Policy Board, Justin Thomas' struggles and if he should be picked for the U.S. Ryder Cup Team, a hidden backyard golf course on Long Island, and more. Lt. Col. Dan Rooney and Kyle Rudolph join the show (1:10:30) to outline a unique Ryder Cup experience through Alltroo and Folds of Honor. They also discuss being a Fighter Jet Pilot, having a “dark visor down” mentality, comparing nerves on the golf course, catching Tom Brady's final regular season touchdown pass, and much more.You can find every episode of this show on Apple Podcasts, Spotify or YouTube. Prime Members can listen ad-free on Amazon Music. For more, visit barstool.link/foreplaypod

Stugotz is joined by Mike Golic and Mikey A to rehash what happened in Tahoe at the golf tournament. Kyle Rudolph talks about playing worse than "Mr. Golic" and his glory days with the Golic family at Notre Dame. Plus, what exactly happened to Mike's first home at Notre Dame. Learn more about your ad choices. Visit megaphone.fm/adchoices